ARTIVION INC (AORT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AORT • US2289031005

39.46 USD
-0.61 (-1.52%)
At close: Feb 5, 2026
39.46 USD
0 (0%)
After Hours: 2/5/2026, 8:09:26 PM
Fundamental Rating

5

Taking everything into account, AORT scores 5 out of 10 in our fundamental rating. AORT was compared to 186 industry peers in the Health Care Equipment & Supplies industry. AORT has an average financial health and profitability rating. AORT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year AORT has reported negative net income.
  • In the past year AORT had a positive cash flow from operations.
  • In the past 5 years AORT always reported negative net income.
  • In multiple years AORT reported negative operating cash flow during the last 5 years.
AORT Yearly Net Income VS EBIT VS OCF VS FCFAORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • AORT has a Return On Assets of -1.06%. This is in the better half of the industry: AORT outperforms 72.04% of its industry peers.
  • AORT has a Return On Equity of -2.08%. This is in the better half of the industry: AORT outperforms 72.04% of its industry peers.
  • The Return On Invested Capital of AORT (2.28%) is better than 68.82% of its industry peers.
Industry RankSector Rank
ROA -1.06%
ROE -2.08%
ROIC 2.28%
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
AORT Yearly ROA, ROE, ROICAORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • AORT has a better Operating Margin (5.26%) than 69.89% of its industry peers.
  • AORT's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 64.50%, AORT is in the better half of the industry, outperforming 68.28% of the companies in the same industry.
  • AORT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.26%
PM (TTM) N/A
GM 64.5%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
AORT Yearly Profit, Operating, Gross MarginsAORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • AORT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for AORT has been increased compared to 1 year ago.
  • AORT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AORT is higher compared to a year ago.
AORT Yearly Shares OutstandingAORT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AORT Yearly Total Debt VS Total AssetsAORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.52 indicates that AORT is not in any danger for bankruptcy at the moment.
  • AORT has a Altman-Z score of 3.52. This is in the better half of the industry: AORT outperforms 72.04% of its industry peers.
  • The Debt to FCF ratio of AORT is 12.48, which is on the high side as it means it would take AORT, 12.48 years of fcf income to pay off all of its debts.
  • AORT has a better Debt to FCF ratio (12.48) than 71.51% of its industry peers.
  • AORT has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.50, AORT is in line with its industry, outperforming 41.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.48
Altman-Z 3.52
ROIC/WACC0.22
WACC10.26%
AORT Yearly LT Debt VS Equity VS FCFAORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 3.93 indicates that AORT has no problem at all paying its short term obligations.
  • AORT has a better Current ratio (3.93) than 67.74% of its industry peers.
  • AORT has a Quick Ratio of 2.88. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.88, AORT is in the better half of the industry, outperforming 65.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.93
Quick Ratio 2.88
AORT Yearly Current Assets VS Current LiabilitesAORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • AORT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.71%.
  • Looking at the last year, AORT shows a quite strong growth in Revenue. The Revenue has grown by 9.81% in the last year.
  • Measured over the past years, AORT shows a small growth in Revenue. The Revenue has been growing by 7.06% on average per year.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%

3.2 Future

  • The Earnings Per Share is expected to grow by 46.17% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 11.94% on average over the next years. This is quite good.
EPS Next Y146.65%
EPS Next 2Y74.67%
EPS Next 3Y51.54%
EPS Next 5Y46.17%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AORT Yearly Revenue VS EstimatesAORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
AORT Yearly EPS VS EstimatesAORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • AORT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 87.33, AORT can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, AORT is valued a bit cheaper than 66.13% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.20, AORT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 87.33
AORT Price Earnings VS Forward Price EarningsAORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 66.13% of the companies listed in the same industry.
  • 69.35% of the companies in the same industry are more expensive than AORT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 106.81
EV/EBITDA 44.53
AORT Per share dataAORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AORT's earnings are expected to grow with 51.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.67%
EPS Next 3Y51.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AORT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARTIVION INC

NYSE:AORT (2/5/2026, 8:09:26 PM)

After market: 39.46 0 (0%)

39.46

-0.61 (-1.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-12
Inst Owners87.09%
Inst Owner ChangeN/A
Ins Owners4.09%
Ins Owner Change-5.24%
Market Cap1.87B
Revenue(TTM)422.65M
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (33.68%)
Short Float %3.69%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)0%
PT rev (3m)14.27%
EPS NQ rev (1m)-6.66%
EPS NQ rev (3m)14.29%
EPS NY rev (1m)4.43%
EPS NY rev (3m)78.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 87.33
P/S 4.42
P/FCF 106.81
P/OCF 61.37
P/B 4.26
P/tB 67.1
EV/EBITDA 44.53
EPS(TTM)-0.26
EYN/A
EPS(NY)0.45
Fwd EY1.15%
FCF(TTM)0.37
FCFY0.94%
OCF(TTM)0.64
OCFY1.63%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.06%
ROE -2.08%
ROCE 2.88%
ROIC 2.28%
ROICexc 2.52%
ROICexgc 6.11%
OM 5.26%
PM (TTM) N/A
GM 64.5%
FCFM 4.14%
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.48
Debt/EBITDA 4.81
Cap/Depr 56.35%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 67.34%
Profit Quality N/A
Current Ratio 3.93
Quick Ratio 2.88
Altman-Z 3.52
F-Score5
WACC10.26%
ROIC/WACC0.22
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y146.65%
EPS Next 2Y74.67%
EPS Next 3Y51.54%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year116.09%
EBIT Next 3Y44.04%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%

ARTIVION INC / AORT FAQ

Can you provide the ChartMill fundamental rating for ARTIVION INC?

ChartMill assigns a fundamental rating of 5 / 10 to AORT.


What is the valuation status of ARTIVION INC (AORT) stock?

ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.


Can you provide the profitability details for ARTIVION INC?

ARTIVION INC (AORT) has a profitability rating of 4 / 10.